NIH and NIDA Directors Address COVID-19 and the HEAL Initiative

Francis S. Collins, Ph.D., director of the National Institutes of Health (NIH), and Nora Volkow, Ph.D., director of the National Institute on Drug Abuse (NIDA), discussed the latest developments of the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM at a virtual plenary session at this year’s Rx Drug Abuse & Heroin Summit.

They discuss the impact of COVID-19 on Substance Use Disorders (SUD) research.

$900 million had been deployed for research on SUD. But due to COVID, the clinical trials had to stop because of the refocus to COVID solutions and the difficulty to safely recruit patients for the trials. Clinical trials across the board have been halted for any therapies other than those for life-threatening drugs.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Need help now?

If you or someone you know needs help immediately, please call 911,
or text START to 741-741 or call 1-800-273 TALK (8255).